Showing results (21-30 of 375) with videos related to
Sort By:
Pageof 38
World Journal of Nuclear Medicine|August 22, 2024
Complimentary Role of [18F]FDG and [18F]NaF-PET/CT in Evaluating Synchronous Thyroid Carcinoma and Parathyroid Adenoma with Brown TumorsYeshwanth Edamadaka, Rahul V Parghane, Sandip BasuIndian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|November 24, 2025
Tissue and Organ-specific Tumor Heterogeneity on dual tracer PET-CT ([<sup>68</sup>Ga] Ga-PSMA-11 and [<sup>18</sup>F] FDG) and Dural-based Brain metastasis in Metastatic Prostate CancerYeshwanth Edamadaka, Rahul V Parghane, Sandip BasuClinical Nuclear Medicine|January 9, 2025
Central Nervous System Tumor-Embryonal Tumors Type With Neuroendocrine DifferentiationYeshwanth Edamadaka, Rahul V Parghane, Sandip BasuWorld Journal of Nuclear Medicine|December 16, 2024
Aggressive Metastatic Insulinoma in a Patient of Diabetes Mellitus with Documentation on Dual-Tracer PET-CT ([68Ga]Ga-DOTATATE and [18F]FDG): Clinical Benefits with Combined Chemo-PRRT ApproachYeshwanth Edamadaka, Rahul V Parghane, Sandip BasuWorld Journal of Nuclear Medicine|May 2, 2019
Prevalence of hitherto unknown brain meningioma detected on <sup>68</sup>Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of <sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumorsRahul V Parghane, Sanjay Talole, Sandip BasuClinical Nuclear Medicine|June 16, 2026
Targeted Alpha Therapy With [225Ac]Ac-DOTATATE Versus Salvage Retreatment PRRT With [177Lu]Lu-DOTATATE in Progressive Metastatic Neuroendocrine Tumor Patients After Initial Course of [177Lu]Lu-DOTATATE Treatment: An Observational Study Comparing the Therapeutic Response, Survival, and Clinical ToxicityRoopal Agrawal, Rahul V Parghane, Sandip BasuClinical Nuclear Medicine|January 29, 2025
Tumor Lesion Uptake of [ 177 Lu]Lu-DOTA-Rituximab in Skeletal and Splenic Disease in Diffuse Large B-Cell LymphomaYeshwanth Edamadaka, Rahul V Parghane, Sandip BasuWorld Journal of Nuclear Medicine|February 17, 2025
Progressive Unilateral Proptosis and [ <sup>18</sup> F]FDG-Avid Lesions Connoting Aggressive Disease in Radioiodine-Refractory Differentiated Thyroid CarcinomaYeshwanth Edamadaka, Rahul V Parghane, Sandip BasuWorld Journal of Nuclear Medicine|February 17, 2025
Rare Combination of Multiple Endocrine Neoplasia 1 with Medullary Thyroid Carcinoma and Clinical Value of <sup>68</sup> Ga-DOTATATE PET/CT in Diagnosing Different Lesions and Exploring Theranostic StrategyParth Baberwal, Rahul V Parghane, Sandip BasuWorld Journal of Nuclear Medicine|December 16, 2024
Portal Venous Tumor Thrombosis and Visceral Organ Metastasis without Skeletal Involvement in mCRPC: Adverse Prognostic Indicators on Dual Tracer PET/CT and Clinical Outcome after <sup>177</sup> Lu-PSMA-617 PRLT and Cabazitaxel TherapyYeshwanth Edamadaka, Rahul V Parghane, Sandip BasuPageof 38